Clinical Trials Browser

Phase 1/2 × Advanced Malignant Solid Tumours × 1 year × Clear all

NCT06888830 2025-06-19

A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumours